NEFL and amyotrophic lateral sclerosis: Critically, we observe a trend of increasing concentrations of plasma Nf‐L ICs and Nf Abs in the longitudinal follow‐up of fast progressing ALS and in ALS patients with a C9orf72 mutation (Fig. 5).